KR100637282B1 - Ｂ형 간염 바이러스 폴리펩티드 - Google Patents

Ｂ형 간염 바이러스 폴리펩티드 Download PDF

Info

Publication number
KR100637282B1
KR100637282B1 KR1020007002945A KR20007002945A KR100637282B1 KR 100637282 B1 KR100637282 B1 KR 100637282B1 KR 1020007002945 A KR1020007002945 A KR 1020007002945A KR 20007002945 A KR20007002945 A KR 20007002945A KR 100637282 B1 KR100637282 B1 KR 100637282B1
Authority
KR
South Korea
Prior art keywords
region
hbv
electrical
polypeptide
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020007002945A
Other languages
English (en)
Korean (ko)
Other versions
KR20010024176A (ko
Inventor
챗필드스티븐네빌
Original Assignee
메데바 유럽 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메데바 유럽 리미티드 filed Critical 메데바 유럽 리미티드
Publication of KR20010024176A publication Critical patent/KR20010024176A/ko
Application granted granted Critical
Publication of KR100637282B1 publication Critical patent/KR100637282B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020007002945A 1997-09-19 1998-09-21 Ｂ형 간염 바이러스 폴리펩티드 Expired - Fee Related KR100637282B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9720033.1A GB9720033D0 (en) 1997-09-19 1997-09-19 Hepatitis B virus polypeptides
GB9720033.1 1997-09-19
PCT/GB1998/002852 WO1999015671A1 (en) 1997-09-19 1998-09-21 Hepatitis b virus polypeptides

Publications (2)

Publication Number Publication Date
KR20010024176A KR20010024176A (ko) 2001-03-26
KR100637282B1 true KR100637282B1 (ko) 2006-10-24

Family

ID=10819394

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007002945A Expired - Fee Related KR100637282B1 (ko) 1997-09-19 1998-09-21 Ｂ형 간염 바이러스 폴리펩티드

Country Status (15)

Country Link
US (1) US20040258709A1 (enExample)
EP (1) EP1015593B1 (enExample)
JP (1) JP2001517447A (enExample)
KR (1) KR100637282B1 (enExample)
AT (1) ATE241013T1 (enExample)
AU (1) AU751646B2 (enExample)
CA (1) CA2304255C (enExample)
CZ (1) CZ297131B6 (enExample)
DE (1) DE69814884T2 (enExample)
ES (1) ES2199460T3 (enExample)
GB (1) GB9720033D0 (enExample)
HU (1) HUP0003511A3 (enExample)
NO (1) NO20001397L (enExample)
PL (1) PL195242B1 (enExample)
WO (1) WO1999015671A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009470D0 (en) 2000-04-17 2000-06-07 Univ Southampton Materials and methods relating to immune responses to fusion proteins
EP1281761A1 (en) * 2001-07-27 2003-02-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Hepatitis B virus pre-S1 derived synthetic polypeptides and their use thereof.
ATE414535T1 (de) 2003-06-23 2008-12-15 Baxter Int Trägerproteine für impfstoffe
CN100537762C (zh) * 2004-06-24 2009-09-09 中国人民解放军军事医学科学院野战输血研究所 一种嵌合型病毒样颗粒疫苗载体蛋白及其制备方法与应用
EP2917231B1 (en) 2012-11-12 2019-03-06 Ruprecht-Karls-Universität Heidelberg Lipopeptides for use in treating liver diseases and cardiovascular diseases
WO2024263918A2 (en) * 2023-06-23 2024-12-26 Brii Biosciences, Inc. Assessment and treatment of chronic hepatitis b

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0389983A2 (en) * 1989-03-31 1990-10-03 Abbott Laboratories Monoclonal antibodies to preS2 and preS1 polypeptides of the hepatitis B viral envelope
WO1994003615A1 (en) * 1992-07-31 1994-02-17 Medeva Holdings B.V. Expression of recombinant fusion proteins in attenuated bacteria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE207535T1 (de) * 1987-06-22 2001-11-15 Medeva Holdings Bv Hepatitis-b-oberflächenantigen enthaltendes peptid
AU4659993A (en) * 1992-07-07 1994-01-31 Merck & Co., Inc. Vaccine comprising mixed pres1+pres2+s and core particle
WO1995004151A2 (en) * 1993-07-30 1995-02-09 Medeva Holdings B.V. Vaccine compositions containing recombinant tetc-fusion proteins
GB9401795D0 (en) * 1994-01-31 1994-03-23 Medeva Holdings Bv Vaccines

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0389983A2 (en) * 1989-03-31 1990-10-03 Abbott Laboratories Monoclonal antibodies to preS2 and preS1 polypeptides of the hepatitis B viral envelope
WO1994003615A1 (en) * 1992-07-31 1994-02-17 Medeva Holdings B.V. Expression of recombinant fusion proteins in attenuated bacteria

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Vaccine Vol. 13(10):933-937 (1995 *

Also Published As

Publication number Publication date
NO20001397L (no) 2000-05-05
US20040258709A1 (en) 2004-12-23
PL195242B1 (pl) 2007-08-31
PL339366A1 (en) 2000-12-18
CA2304255A1 (en) 1999-04-01
CZ297131B6 (cs) 2006-09-13
AU751646B2 (en) 2002-08-22
EP1015593B1 (en) 2003-05-21
DE69814884T2 (de) 2004-03-11
ES2199460T3 (es) 2004-02-16
CA2304255C (en) 2009-07-07
GB9720033D0 (en) 1997-11-19
CZ2000978A3 (cs) 2001-01-17
DE69814884D1 (de) 2003-06-26
HUP0003511A3 (en) 2003-08-28
AU9174498A (en) 1999-04-12
WO1999015671A1 (en) 1999-04-01
NO20001397D0 (no) 2000-03-17
HUP0003511A2 (hu) 2001-02-28
EP1015593A1 (en) 2000-07-05
JP2001517447A (ja) 2001-10-09
ATE241013T1 (de) 2003-06-15
KR20010024176A (ko) 2001-03-26

Similar Documents

Publication Publication Date Title
KR100208129B1 (ko) B형 간염 백신
Schafer et al. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine.
CA1341435C (en) Recombinant pox virus for immunization against tumor-associated antigens
Wu et al. Expression of immunogenic epitopes of hepatitis B surface antigen with hybrid flagellin proteins by a vaccine strain of Salmonella.
Thanavala et al. Immunogenicity of transgenic plant-derived hepatitis B surface antigen.
JP2852515B2 (ja) ベクターウイルスおよびベクターウイルスを含む薬用組成物
JP3616390B2 (ja) Ｂ型肝炎のウイルスに対する細胞障害性ｔリンパ球の応答を誘発するペプチド
KR0165115B1 (ko) 콕시듐증 백신
US6919203B2 (en) Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
PT85137B (pt) Processo de preparacao de um polipeptido de composito imunogenico, de melhoramento da imunogenicidade de um imunogenio e de atenuacao da falta de capacidade de resposta a uma vacina do virus da hepatite b
Hui et al. Immunization with a plasmid encoding a modified hepatitis B surface antigen carrying the receptor binding site for hepatocytes
KR100637282B1 (ko) Ｂ형 간염 바이러스 폴리펩티드
US5851823A (en) Hepatitis B vaccine
AU731706B2 (en) Recombinant viral pseudo-particles and vaccinal and antitumoral applications thereof
Zuckerman New hepatitis B vaccines
JPH02211881A (ja) ＨＩＶに対する中和抗体を誘発するかまたはかかる抗体によって認識され得る免疫原配列を含むＨＢｓＡｇ抗原の形態学的特徴を有する組換えハイブリッドＨＢｓＡｇ粒子、かかる粒子をコードするヌクレオチド配列及び核粒子を含むワクチン
MXPA00002577A (en) Hepatitis b virus polypeptides
WO1991017768A1 (en) Epitopes of the pre-s region of hepatitis b virus surface antigen
US5989865A (en) Hepatitis B vaccine
AU642729C (en) Hepatitis B vaccine
HOWARD et al. Hepatitis Β Virus: Approaches to Control and Vaccination
Epstein Nuffield Department of Clinical Medicine University of Oxford John Radcliffe Hospital, Oxford OX3 9DU, UK

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20091017

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20091017